348 related articles for article (PubMed ID: 25998030)
1. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
3. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
[TBL] [Abstract][Full Text] [Related]
4. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
5. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
[TBL] [Abstract][Full Text] [Related]
7. Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
Emsley R; Asmal L; du Plessis S; Chiliza B; Kidd M; Carr J; Vink M
Schizophr Res; 2015 Dec; 169(1-3):89-94. PubMed ID: 26441006
[TBL] [Abstract][Full Text] [Related]
8. Are negative symptoms really related to cognition in schizophrenia?
Bagney A; Dompablo M; Santabárbara J; Moreno-Ortega M; Lobo A; Jimenez-Arriero MA; Palomo T; Rodriguez-Jimenez R
Psychiatry Res; 2015 Dec; 230(2):377-82. PubMed ID: 26454405
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
11. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
[TBL] [Abstract][Full Text] [Related]
12. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
[TBL] [Abstract][Full Text] [Related]
13. The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
Lindenmayer JP; Fregenti S; Kang G; Ozog V; Ljuri I; Khan A; Goldring A; McGurk SR
Schizophr Res; 2017 Jul; 185():154-160. PubMed ID: 28094171
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
[TBL] [Abstract][Full Text] [Related]
15. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
[TBL] [Abstract][Full Text] [Related]
16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
17. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
[TBL] [Abstract][Full Text] [Related]
18. Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
Fu S; Czajkowski N; Torgalsbøen AK
Psychiatry Res; 2018 Sep; 267():319-326. PubMed ID: 29957548
[TBL] [Abstract][Full Text] [Related]
19. Neurocognition, psychopathology, and subjective disturbances in schizophrenia: a comparison between short-term and remitted patients.
Comparelli A; De Carolis A; Corigliano V; Romano S; Kotzalidis G; Brugnoli R; Tamorri S; Curto M; Tatarelli R; Ferracuti S; Girardi P
Compr Psychiatry; 2012 Oct; 53(7):931-9. PubMed ID: 22444951
[TBL] [Abstract][Full Text] [Related]
20. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]